{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:58Z","timestamp":1792791538545,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cct.2024.107712","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:21:20Z","timestamp":1728606080000},"page":"107712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Active symptom monitoring for premenopausal women with breast cancer initiating adjuvant endocrine therapy: Protocol for the SWOG S2010 randomized controlled efficacy trial"],"prefix":"10.1016","volume":"147","author":[{"given":"N.L.","family":"Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Darke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.C.","family":"Skaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Fisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cct.2024.107712_bb0005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3322\/caac.21583","article-title":"Breast cancer statistics, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.cct.2024.107712_bb0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.18.01160","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO Clinical Practice Guideline Focused Update","volume":"37","author":"Burstein","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1803164","article-title":"Tailoring adjuvant endocrine therapy for premenopausal breast cancer","volume":"379","author":"Francis","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cct.2024.107712_bb0020","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1412379","article-title":"Adjuvant ovarian suppression in premenopausal breast cancer","volume":"372","author":"Francis","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.cct.2024.107712_bb0025","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2015.65.9573","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline update on ovarian suppression","volume":"34","author":"Burstein","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.cct.2024.107712_bb0030","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJM199811263392207","article-title":"Tamoxifen in the treatment of breast cancer","volume":"339","author":"Osborne","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cct.2024.107712_bb0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10549-009-0309-1","article-title":"Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort","volume":"117","author":"Henry","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.cct.2024.107712_bb0040","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/gme.0b013e3181a5d0d6","article-title":"Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy","volume":"16","author":"Otte","year":"2009","journal-title":"Menopause (New York, NY)"},{"issue":"1","key":"10.1016\/j.cct.2024.107712_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/13697131003717070","article-title":"Modeling hot flushes and quality of life in breast cancer survivors","volume":"14","author":"Rand","year":"2011","journal-title":"Climacteric J. Int. Menopause Soc."},{"issue":"16","key":"10.1016\/j.cct.2024.107712_bb0050","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/cncr.24419","article-title":"Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors","volume":"115","author":"Mao","year":"2009","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.cct.2024.107712_bb0055","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1200\/JCO.2011.38.0261","article-title":"Predictors of aromatase inhibitor discontinuation due to treatment-emergent symptoms in early-stage breast cancer","volume":"30","author":"Henry","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.cct.2024.107712_bb0060","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","article-title":"Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer","volume":"25","author":"Crew","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clbc.2017.12.012","article-title":"Effect of aromatase inhibitor therapy on sleep and activity patterns in early-stage breast cancer","volume":"18","author":"Bhave","year":"2018","journal-title":"Clin. Breast Cancer"},{"issue":"10","key":"10.1016\/j.cct.2024.107712_bb0070","doi-asserted-by":"crossref","first-page":"djv216","DOI":"10.1093\/jnci\/djv216","article-title":"The imperative for a new approach to toxicity analysis in oncology clinical trials","volume":"107","author":"Thanarajasingam","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10549-011-1378-5","article-title":"Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)","volume":"128","author":"Oberguggenberger","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.cct.2024.107712_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1010684903199","article-title":"Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for \u2018well-tolerated\u2019 treatments?","volume":"66","author":"Fellowes","year":"2001","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.cct.2024.107712_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11764-020-00908-5","article-title":"How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support","volume":"15","author":"Berkowitz","year":"2021","journal-title":"J. Cancer Surviv."},{"issue":"1","key":"10.1016\/j.cct.2024.107712_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"issue":"21","key":"10.1016\/j.cct.2024.107712_bb0095","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2015.63.8619","article-title":"Treatment adherence and its impact on disease-free survival in the Breast International Group 1-98 trial of tamoxifen and letrozole, alone and in sequence","volume":"34","author":"Chirgwin","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","article-title":"Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer","volume":"126","author":"Hershman","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.cct.2024.107712_bb0105","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/bjc.2013.518","article-title":"A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer","volume":"109","author":"Barron","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.cct.2024.107712_bb0110","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/COC.0000000000000314","article-title":"Patient-reported adherence to adjuvant aromatase inhibitor therapy using the morisky medication adherence scale: an evaluation of predictors","volume":"41","author":"Kesmodel","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0115","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","article-title":"Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review","volume":"134","author":"Murphy","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.cct.2024.107712_bb0120","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/j.clbc.2021.01.007","article-title":"Five-year adjuvant endocrine therapy adherence trajectories among women with breast cancer: a Nationwide French study using administrative data","volume":"21","author":"Lailler","year":"2021","journal-title":"Clin. Breast Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.cct.2024.107712_bb0125","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.2105\/AJPH.2014.302490","article-title":"Racial\/ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review","volume":"105","author":"Roberts","year":"2015","journal-title":"Am. J. Public Health"},{"issue":"27","key":"10.1016\/j.cct.2024.107712_bb0130","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2016.72.0946","article-title":"Treatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trials","volume":"35","author":"Saha","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.cct.2024.107712_bb0135","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1200\/JCO.19.01758","article-title":"Serum detection of nonadherence to adjuvant tamoxifen and breast cancer recurrence risk","volume":"38","author":"Pistilli","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.cct.2024.107712_bb0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11764-014-0374-2","article-title":"Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research","volume":"8","author":"Van Liew","year":"2014","journal-title":"J. Cancer Surviv."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10549-017-4177-9","article-title":"Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer","volume":"163","author":"Salgado","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.cct.2024.107712_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pec.2004.10.005","article-title":"Adherence beliefs among breast cancer patients taking tamoxifen","volume":"59","author":"Grunfeld","year":"2005","journal-title":"Patient Educ. Couns."},{"issue":"16","key":"10.1016\/j.cct.2024.107712_bb0155","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/cncr.28756","article-title":"Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy","volume":"120","author":"Kidwell","year":"2014","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.cct.2024.107712_bb0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10549-018-4713-2","volume":"169","author":"Wagner","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.cct.2024.107712_bb0165","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/annonc\/mds653","article-title":"The Patient\u2019s Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer","volume":"24","author":"Hadji","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cct.2024.107712_bb0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/1471-2407-13-407","article-title":"Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment\u2014the COMPAS study","volume":"13","author":"Ziller","year":"2013","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.cct.2024.107712_bb0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10549-018-5012-7","article-title":"A systematic review of interventions to improve adherence to endocrine therapy","volume":"173","author":"Heiney","year":"2019","journal-title":"Breast Cancer Res. Tr."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jama.2018.8907","article-title":"Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a randomized clinical trial","volume":"320","author":"Hershman","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cct.2024.107712_bb0185","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.2017.74.6651","article-title":"Randomized, multicenter, placebo-controlled clinical trial of duloxetine versus placebo for aromatase inhibitor-associated arthralgias in early-stage breast cancer: SWOG S1202","volume":"36","author":"Henry","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.cct.2024.107712_bb0190","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1200\/JCO.2008.19.6253","article-title":"Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis","volume":"27","author":"Loprinzi","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.cct.2024.107712_bb0195","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American cancer society\/american society of clinical oncology breast cancer survivorship care guideline","volume":"34","author":"Runowicz","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/j.cct.2024.107712_bb0200","article-title":"Use of physical activity (PA) and supportive care (SC) among patients (pts) with early breast cancer (BC) reporting cancer-related fatigue (CRF)","volume":"31","author":"Di Meglio","year":"2002","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.cct.2024.107712_bb0205","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.cct.2024.107712_bb0215","doi-asserted-by":"crossref","first-page":"djx029","DOI":"10.1093\/jnci\/djx029","article-title":"Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients","volume":"109","author":"Denis","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cct.2024.107712_bb0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1472-6963-13-211","article-title":"A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.cct.2024.107712_bb0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcpo.2017.12.001","article-title":"Cost-effectiveness of symptom monitoring with patient-reported outcomes during routine cancer treatment","volume":"15","author":"Nixon","year":"2018","journal-title":"J. Cancer Policy"},{"issue":"5","key":"10.1016\/j.cct.2024.107712_bb0230","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00520-017-3970-7","article-title":"Chemotherapy-related neuropathic symptom management: a randomized trial of an automated symptom-monitoring system paired with nurse practitioner follow-up","volume":"26","author":"Kolb","year":"2018","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.cct.2024.107712_bb0235","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cardfail.2017.09.009","article-title":"Implementation of real-time assessment of patient-reported outcomes in a heart failure clinic: a feasibility study","volume":"23","author":"Stehlik","year":"2017","journal-title":"J. Card. Fail."},{"issue":"8","key":"10.1016\/j.cct.2024.107712_bb0240","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.2010.29.8315","article-title":"Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial","volume":"29","author":"Cleeland","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.cct.2024.107712_bb0245","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1200\/JCO.20.02015","article-title":"Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy","volume":"39","author":"Absolom","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 4","key":"10.1016\/j.cct.2024.107712_bb0250","article-title":"A pragmatic cluster-randomized trial of Ambulatory Toxicity Management in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer (The AToM Study)","volume":"31","author":"Krzyzanowska","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cct.2024.107712_bb0255","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1200\/JCO.19.02699","article-title":"Randomized trial of text messaging to reduce early discontinuation of adjuvant aromatase inhibitor therapy in women with early-stage breast cancer: SWOG S1105","volume":"38","author":"Hershman","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cct.2024.107712_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.17.00015","article-title":"Bidirectional text messaging to monitor endocrine therapy adherence and patient-reported outcomes in breast cancer","volume":"1","author":"Mougalian","year":"2017","journal-title":"JCO Clin. Cancer Inform."},{"issue":"1","key":"10.1016\/j.cct.2024.107712_bb0265","doi-asserted-by":"crossref","DOI":"10.1177\/1073274819883287","article-title":"Increasing adherence to adjuvant hormone therapy among patients with breast cancer: a smart phone app-based pilot study","volume":"26","author":"Krok-Schoen","year":"2019","journal-title":"Cancer Control."},{"issue":"3","key":"10.1016\/j.cct.2024.107712_bb0270","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1200\/OP.20.00118","article-title":"Electronic patient reporting of adverse events and quality of life: a prospective feasibility study in general oncology","volume":"17","author":"Kennedy","year":"2020","journal-title":"JCO Oncol. Pract."},{"issue":"28","key":"10.1016\/j.cct.2024.107712_bb0275","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1200\/JCO.23.00697","article-title":"A systematic review and meta-analysis of interventions to promote adjuvant endocrine therapy adherence among breast cancer survivors","volume":"41","author":"Bright","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cct.2024.107712_bb0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1200\/EDBK_159514","article-title":"Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"35","author":"Kluetz","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"10","key":"10.1016\/j.cct.2024.107712_bb0285","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1007\/s10620-019-05621-7","article-title":"Content validity and reliability of a self-report measure of medication nonadherence in hepatitis C treatment","volume":"64","author":"Voils","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0290","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1006263818115","article-title":"Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B","volume":"55","author":"Fallowfield","year":"1999","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3959(83)90143-4","article-title":"Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases","volume":"17","author":"Daut","year":"1983","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.cct.2024.107712_bb0300","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008","volume":"63","author":"Cella","year":"2010","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.cct.2024.107712_bb0305","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bjhp.12003","article-title":"Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer","volume":"18","author":"Corter","year":"2013","journal-title":"Br. J. Health Psychol."},{"issue":"2","key":"10.1016\/j.cct.2024.107712_bb0310","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4104\/pcrj.2011.00005","article-title":"The influence of personality traits and beliefs about medicines on adherence to asthma treatment","volume":"20","author":"Emilsson","year":"2011","journal-title":"Prim. Care Respir. J."},{"issue":"7","key":"10.1016\/j.cct.2024.107712_bb0315","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s11136-017-1527-3","article-title":"Validation of the PROMIS((R)) measures of self-efficacy for managing chronic conditions","volume":"26","author":"Gruber-Baldini","year":"2017","journal-title":"Qual. Life Res."},{"issue":"6","key":"10.1016\/j.cct.2024.107712_bb0320","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.cct.2024.107712_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","article-title":"The Beliefs about Medicines Questionnaire (BMQ): the development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","year":"1999","journal-title":"Psychol. Health"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424002957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424002957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T09:01:15Z","timestamp":1733130075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714424002957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"alternative-id":["S1551714424002957"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2024.107712","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active symptom monitoring for premenopausal women with breast cancer initiating adjuvant endocrine therapy: Protocol for the SWOG S2010 randomized controlled efficacy trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2024.107712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107712"}}